• Mirtazapine API CAS 85650-52-8 Ep 99%+
  • Mirtazapine API CAS 85650-52-8 Ep 99%+
  • Mirtazapine API CAS 85650-52-8 Ep 99%+
  • Mirtazapine API CAS 85650-52-8 Ep 99%+
  • Mirtazapine API CAS 85650-52-8 Ep 99%+
  • Mirtazapine API CAS 85650-52-8 Ep 99%+

Mirtazapine API CAS 85650-52-8 Ep 99%+

CAS No.: 85650-52-8
Formula: C17h19n3
EINECS: 288-060-6
Type: Pharmaceutical API
Appearance: Powder
Quality: Refined
Samples:
US$ 1/g 1 g(Min.Order)
| Request Sample
Customization:
Gold Member Since 2015

Suppliers with verified business licenses

Manufacturer/Factory

Basic Info.

Model NO.
EP 99%+
Colour
White
Water
2.8%
Sulfated Ash
0.05%
Ethanol
<200ppm
Individual Impurity
<0.03%
Total Impurity
<0.03%
Transport Package
25kg/Drum
Specification
25kg/drum
Trademark
JINLAN PHARM
Origin
China
Production Capacity
1000kg/Month

Product Description


Mirtazapine is indicated for moderate to severe depressive disorder and is effective for symptoms such as anhedonia, psychomotor inhibition, poor sleep (early awakening), and weight loss.

Quick Details:
Name: 
Mirtazapine API
CAS No.: 85650-52-8
Place of Origin: China (Mainland)
Grade Standard: Pharmaceutical Grade
Brand Name: JINLAN PHARM
We recommend T/T or Escrow , D/P,D/A, Western Union or PayPal are also acceptable!

 
Delivery:
In about 3 working days after the receipt of payment, we will follow up the delivery until you receive it.
Express way as the following is:
(Shipping : TNT, Fedex, DHL,USP,EMS and so on)

(By air,by sea,by rail...)
 
Packaging: 
Drum & plastic bags, Aluminum foiled bag, Zip lock bags 
Our Company:
Our company advantage:
1.Small order is acceptable
2.Can provide sample for you
3.Have self-export rights

 

CONTACT US:
Jinlan Pharm-Drugs Technology Co., Limited
Hangzhou Royall Import & Export Co.,Ltd.
Add:Room 1701, Building 3, Greenland Central Plaza, No.98 Daguan Road, Gongshu District, Hangzhou


Here we attached our COA of one of batches for your reference:

Mirtazapine API CAS 85650-52-8 Ep 99%+

Hangzhou Jinlan Pharm-Drugs Technology Co., Ltd. (JL Pharm) is established in 2012 at the beautiful West Lake - Hangzhou city, China. The company's main business includes R&D, Production and Sales of Formulation, APIs, and intermediates. The company's main products include Anti-COVID products, Contrast Media, related formulation, intermediates, and new product development.

We has a laboratory of 1200 square meters in Nanjing city, and has cooperative GMP production plants in Beijing, Jiangsu, Zhejiang, Jiangxi, Chengdu and Shandong. We have more than 80 technical staff, the company's management team has experience in R&D, GMP production, analysis, registration, etc. The technical management level is in a leading position in the pharmaceutical industry. We provide CDMO technology research and development services, and provides a full range of laboratory R&D and production services for raw materials and pharmaceutical intermediates to global pharmaceutical companies, including synthetic route research and development, process research and development and optimization, scale-up production, domestic and foreign drug registration, and industrial equipment selection, automatic control system and technical process packages.

Based on the philosophy of "Human-orient, Technical first, Quality product and High efficiency, Fact and Innovation", JL Pharm highly welcome friends from all over the world to cooperate and get co-development.


Mirtazapine API CAS 85650-52-8 Ep 99%+Mirtazapine API CAS 85650-52-8 Ep 99%+Mirtazapine API CAS 85650-52-8 Ep 99%+Mirtazapine API CAS 85650-52-8 Ep 99%+Mirtazapine API CAS 85650-52-8 Ep 99%+Mirtazapine API CAS 85650-52-8 Ep 99%+Mirtazapine API CAS 85650-52-8 Ep 99%+Mirtazapine API CAS 85650-52-8 Ep 99%+



 

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now

You Might Also Like

Gold Member Since 2015

Suppliers with verified business licenses

Manufacturer/Factory
Registered Capital
5000000 RMB
Plant Area
501~1000 square meters